Molecular dynamics reveals how calcium influences collagen assembly, indicating implications for age-related diseases.
Type I collagen is the main structural protein of vertebrates and forms molecular trimers from the COL1A1 and COL1A2 gene products: proα1α(I) and proα2α(I), during biosynthesis. Calcium ions are required for trimers to form. The amino acid sequence of the C-propeptide of collagen, which is removed before collagen fibril formation, initially drives heterotrimerisation. Abnormal homotrimeric type I collagen is associated with age-related diseases including cancer, fibrosis, musculoskeletal and cardiovascular conditions but the circumstances under which the homotrimer may form are poorly understood. Here we used molecular dynamics simulations of the C-propeptide protein structure to show that inter- and intra-chain hydrogen bonding is affected by loss of calcium and that this leads chains to become destabilised, particularly at the interfaces of each chain. Loss of calcium resulted increased distances between the cysteine residues that form inter-chain disulphide bonds, preventing the formation of these bonds. Pulling simulations and modelling of calcium dissociation from monomers showed that calcium ions were more strongly bound to the α1(I) than the α2(I) chain. However, enhanced sampling methods implied the α2(I) chain has a higher trimer affinity than a third α1(I) chain in the presence of structural calcium. To quantify assembly thermodynamics, we computed relative binding free energies by alchemical thermodynamic integration, demonstrating that α2(I)-specific residues at the interchain interface conferred a measurable thermodynamic advantage to trimer formation in the presence of calcium. Hence although heterotrimerisation is normally favoured, in reduced calcium conditions the homotrimer can form by sequestering available calcium to the α1(I) chains. This study provides a molecular explanation for a calcium-based mechanism driving heterotrimerisation versus homotrimerisation of type I collagen.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: